IRVINE, Calif., Sept. 2 (HSMN NewsFeed) — Cardiogenesis Corporation (OTCQB: CGCP), released comments today regarding the STAR-heart study. The STAR-heart study, which was presented at the European Society of Cardiology 2010 Congress in August 2010, r…
Regenerative Medicine, Devices, Cardiology
Cardiogenesis, STAR-heart study, stem cell, heart failure, cardiomyopathy

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Cardiogenesis Comments on the STAR-Heart Study Presented at European Society of Cardiology (ESC) 2010 Congress”
Leave a Comment